PROTEIN NANO FACTORY
DEAD

Serial Number

98634895

Owner

SPOC Proteomics Inc

Filing Date

Jul 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PROTEIN NANO FACTORY Trademark

Serial Number: 98634895

PROTEIN NANO FACTORY is a trademark filed by SPOC Proteomics Inc on July 5, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

SPOC Proteomics Inc (12 trademarks)

7201 E Henkel Way, Suite 285
Scottsdale, AZ 85255

Entity Type: 03

Trademark Details

Filing Date

July 5, 2024

Registration Date

Not Registered

Goods & Services

Bioreactor for cell culturing; Bioreactors for cell culturing for scientific research; Bioreactors for laboratory use; Diagnostic apparatus for testing food; Filters used in scientific and forensic apparatus in drug detection processes; Gas testing instruments; Imaging apparatus and instruments for the study of proteins for agricultural purposes; Imaging apparatus and instruments for use in the study of proteins and peptides in drug development; Laboratory apparatus and chromatography systems for use in protein purification; Laboratory apparatus and computer systems for use in protein purification; Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; Scientific apparatus, namely, spectrophotometer for measuring relative DNA, RNA and protein; Semiconductor testing apparatus

Drug discovery services; Drug screening for forensic purposes; Drug screening for scientific research purposes; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Research and development in the field of biochemistry; Research and development in the field of biotechnology; Research and development in the field of diagnostic preparations; Research and development in the field of microorganisms and cells; Research and development in the pharmaceutical and biotechnology fields; Research and development of medicines; Research and development of new products; Research and development of new products for others; Research and development of pharmaceutical preparations for treating malignant tumours; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of technology in the field of power conversion; Research and development of vaccines; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research and development services in the field of biotechnology; Research and development services in the field of chemistry; Research and development services in the field of cosmetics; Research and development services in the field of cytology; Research and development services in the field of diagnostic preparations; Research and development services in the field of engineering; Research and development services in the field of food; Research and development services in the field of gene expression systems; Research and development services in the field of genomics; Research and development services in the field of immunohistology; Research and development services in the field of immunology; Research and development services in the field of medical preparations; Research and development services in the field of microorganisms and cells; Research and development services in the field of nutritional supplements; Research and development services in the field of pharmaceutical preparations; Research and development services of new pharmaceutical products; Research and development services relating to medicines; Research and development services relating to vaccines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Testing of chemicals; Testing of cosmetics; Testing of materials; Testing of pharmaceuticals; Bacteriological research and testing; Biochemical research and development; Biochemical research and development services; Consulting services in the field of pharmaceutical research and development; Environmental testing and inspection services; Laboratory testing of materials; Material testing and analysis; Material testing services; Materials testing; Materials testing services; Medical and scientific research in the field of cancer treatment and diagnosis; Pharmaceutical drug development services; Product research and development; Product testing; Product quality testing services; Product safety testing; Product safety testing services; Research and development of mRNA drugs; Research and development of siRNA drugs; Scientific research and development; Vaccine research and development; Vaccine research and development services

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 16, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 16, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 30, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 30, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 30, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2025 NWOS
NEW APPLICATION ENTERED
Jul 5, 2024 NWAP